Cardio-oncology and COVID 19: Lessons learned, past reflections and future deliberations

Brown, Sherry-Ann

doi:10.1016/j.ahjo.2022.100137

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been shown in subsequent meta-analysis results that COVID-19 patients have an increase amount of cancer prevalence and risk of death. Some governments categorized cancer and cardiovascular patients having high risk of virus infection and severe clinical course in COVID-19 pandemic [13,14]. There is evidences of increased mortality and morbidity rates in COVID-19 patients with comorbid cancer and cardiovascular.…”

Section: Introductionmentioning

confidence: 99%

Cardio-Oncology and the COVID-19 Pandemic

Mortezaei¹,

Hosseini²

2023

Novel Pathogenesis and Treatments for Cardiovascular Disease

View full text Add to dashboard Cite

As one of the novel interesting fields of cardiology, cardio-oncology focuses on monitoring, detecting, and treating cardiovascular diseases caused due to chemotherapy or radiotherapy side effects. It has been observed that cardiovascular patients have a higher risk of viral infections and poorer treatment outcomes. COVID-19 is a disease caused by the new coronavirus, SARS-CoV-2, which emerged in Wuhan, China, in 2019 and then distributed worldwide. Recent evidence showed that the risk of COVID-19 and its mortality rate is higher in patients suffering from cardiovascular side effects of cancer therapies. Additional diagnosis complexity in cardio-oncology is another problem due to overlapping with COVID-19. Therefore, the cardio-oncology community had to re-evaluate the best clinical care in the COVID-19 pandemic. The present study aims to review previous studies focusing on the interaction between COVID-19 and cardio-oncology, which will pave the way for studying human diseases overlapping with COVID-19.

show abstract

Section: Introductionmentioning

confidence: 99%